Nuvig Therapeutics is developing drugs that tap into one of the body's natural mechanisms for controlling inflammation. Co-founder and CEO Pamela Conley, a veteran of Portola Pharmaceuticals, says Nuvig's approach could offer efficacy similar to currently available autoimmune drugs but with a better safety profile.
This event will bring together healthcare futurists, novel employers, payers, providers, and forward-thinking investors and entrepreneurs who support the broad transformation being spearheaded by digital health technologies.
Register by Friday, June 3rd to Save $200* with the Extreme Early Bird Rate
By Michael Schroeder Wednesday, May 11, 2022 8:01 PM
The Dublin, Ireland-based device maker has the first system cleared by the FDA that uses artificial intelligence to detect potential signs of colon cancer. Research recently suggested that combined with colonoscopy, AI could improve colon cancer prevention and reduce costs for patients.
While many leading health systems are working to hire and train aggressively, there will be a point when money will no longer matter and all the incentives in the world won't be enough to attract or retain talent. That's why most clinicians, IT leaders and administrators are dedicating more time, money, and effort in adopting technology and rearchitecting care models.
Nuvig Therapeutics is developing drugs that tap into one of the body's natural mechanisms for controlling inflammation. Co-founder and CEO Pamela Conley, a veteran of Portola Pharmaceuticals, says Nuvig's approach could offer efficacy similar to currently available autoimmune drugs but with a better safety profile.
By Michael Schroeder Wednesday, May 11, 2022 1:53 PM
Pulling back the curtain on healthcare pricing is easier said than done, acknowledged Chris Severn, the company's co-founder and CEO. That's exactly why the investment is so important.
Roche reported that its drug tiragolumab failed to achieve one of two main goals of a Phase 3 study in non-small cell lung cancer. The antibody is designed to block TIGIT, a checkpoint protein that has been a hot target for pharmaceutical companies looking for a way to broaden the reach of cancer immunotherapy.
The most effective way for healthcare leaders to support providers is to relieve operational and administrative burdens, and this should begin with the onboarding process.
Leaders should be proactive about investing in IT to avoid costly issues in the future. Examine existing technology for potential risks and redundancies, assess system performance, and establish forward-looking goals and benchmarks.
No comments